Patent US4791926A successfully refreshed from Google Patents.
US5389535A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of encapsulating cells in a tubular extrudate
Assignee: Brown University Research Foundation Inc
•
Filing: 1993-12-17
•
Granted: 1995-02-14
•
Expires: 2013-12-17
Abstract
Abstract Methods and systems are disclosed for encapsulating viable cells which produce biologically-active factors. The cells are encapsulated within a semipermeable, polymeric membrane by co-extruding an aqueous cell suspension and a polymeric solution through a common port to form a tubular extrudate having a polymeric outer coating which encapsulates the cell suspension. For example, the cell suspension and the polymeric solution can be extruded through a common extrusion port having at least two concentric bores, such that the cell suspension is extruded through the inner bore and the polymeric solution is extruded through the outer bore. The polymeric solution coagulates to form an outer coating. As the outer coating is formed, the ends of the tubular extrudate can be sealed to form a cell capsule. In one embodiment, the tubular extrudate is sealed at intervals to define separate cell compartments connected by polymeric links.
Inventors
- 👤 Patrick Aebischer
- 👤 Lars Wahlberg
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:14
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0087; A61K9/0092; A61F; A61F2/00; A61F2/02; A61F2/022; A61K35/00; A61K35/12; A61K9/0012; A61K9/0019; A61K9/0024; A61K9/0085; A61K9/48; A61K9/4816; A61K9/4833; A61M; A61M31/00; A61M31/002; B; B01; B01J; B01J13/00; B01J13/02; B01J13/04; C; C12; C12N; C12N11/00; C12N11/02; C12N11/04; C12N11/08; C12N11/082; C12N11/087; C12N11/098; C12N5/00; C12N5/0012; C12N5/06; C12N5/0602; C12N5/0613; C12N5/0614; C12N5/0618; C12N5/0619; A61K2035/126; A61K2035/128; A61M2210/00; A61M2210/06; A61M2210/0687; A61M2210/0693; C12N2533/00; C12N2533/30
Claims Analysis
Total Claims: 21
Claim 1
Independent Claim
120 words
A method of encapsulating viable cells comprising co-extruding an aqueous cell suspension and a polymeric solution through a common port having at least two concentric bores to form a tubular extrudate having a polymeric outer coating which encapsulates said cell suspension, wherein said cell suspension is extruded through an inner bore and said polymeric solution is extruded through an outer bore and a pressure differential is maintained between said cell suspension and said polymeric solution during co-extrusion to impede solvent diffusion from said polymeric solution into said cell suspension, and said polymeric solution and said cell suspension are chosen so that coagulation of said polymeric solution occurs as the polymeric solution and cell suspension are extruded through the extrusion port.
Claim 2
Independent Claim
120 words
A method of encapsulating viable cells comprising co-extruding an aqueous cell suspension and a polymeric solution through a common port having at least two concentric bores to form a tubular extrudate having a polymeric outer coating which encapsulates said cell suspension, wherein said cell suspension is extruded through an inner bore and said polymeric solution is extruded through an outer bore and a pressure differential is maintained between said cell suspension and said polymeric solution during co-extrusion to impede solvent diffusion from said polymeric solution into said cell suspension, and said polymeric solution and said cell suspension are chosen so that coagulation of said polymeric solution occurs as the polymeric solution and cell suspension are extruded through the extrusion port.
Claim 3
Dependent Claim
14 words
The method of claim 1 wherein the extrusion port is in contact with air.
Claim 4
Dependent Claim
14 words
The method of claim 1 wherein the extrusion port is in contact with quenchent.
Claim 5
Dependent Claim
16 words
The method of claim 1 wherein said cell suspension comprises cells that secrete a biologically-active factor.
Claim 6
Dependent Claim
15 words
The method of claim 1 wherein said cell suspension comprises cells that secrete a neurotransmitter.
Claim 7
Dependent Claim
14 words
The method of claim 1 wherein said cell suspension further comprises a nutrient medium.
Claim 8
Dependent Claim
15 words
The method of claim 1 wherein said cell suspension further comprises an anchorage substrate material.
Claim 9
Dependent Claim
15 words
The method of claim 1 wherein said polymeric solution further comprises a water-miscible solvent component.
Claim 10
Dependent Claim
13 words
The method of claim 1 wherein said polymeric solution further comprises a surfactant.
Claim 11
Dependent Claim
14 words
The method of claim 1 wherein said polymeric solution further comprises an anti-inflammatory agent.
Claim 12
Dependent Claim
13 words
The method of claim 1 wherein said polymeric solution further comprises an antioxidant.
Claim 13
Dependent Claim
34 words
The method of claim 1 wherein the method further comprises controlling the viscosity of said polymeric solution, such that upon coagulation said outer polymeric coating will form a semipermeable membrane about said cell suspension.
Claim 14
Dependent Claim
20 words
A tubular extrudate comprising a semipermeable, polymeric membrane encapsulating a viable cell culture prepared by the method of claim 1.
Claim 15
Dependent Claim
22 words
The tubular extrudate of claim 13 wherein the membrane is permeable to molecules having a molecular weight of about 150,000 or less.
Claim 16
Dependent Claim
23 words
The tubular extrudate of claim 13 wherein the maximum outer diameter of the tubular extrudate ranges from abut 0.1 to about 1.0 millimeters.
Claim 17
Dependent Claim
21 words
The tubular extrudate of claim 13 wherein the membrane has a wall thickness ranging from abut 10 to about 100 microns.
Claim 18
Dependent Claim
15 words
The tubular extrudate of claim 13 wherein the polymeric membrane further comprises a polyacrylate material.
Claim 19
Dependent Claim
14 words
The tubular extrudate of claim 13 wherein the polymeric membrane further comprises a surfactant.
Claim 20
Dependent Claim
15 words
The tubular extrudate of claim 20 wherein the polymeric membrane further comprises an anti-inflammatory agent.
Claim 21
Dependent Claim
14 words
The tubular extrudate of claim 13 wherein the polymeric membrane further comprises an anti-oxidant.
References Cited (Backward Citations)
US3093831A
Cited
US3715277A
Cited
US3821087A
Cited
US3962383A
Cited
US3947325A
Cited
US4324683A
Cited
US4251195A
Cited
US4426337A
Cited
US4163691A
Cited
US4288494A
Cited
US4333906A
Cited
US4241187A
Cited
US4409331A
Cited
US4391909A
Cited
US4352883A
Cited
US4451253A
Cited
US4353888A
Cited
US4495288A
Cited
US4378016A
Cited
US4402694A
Cited
EP0116311A1
Cited
US4695466A
Cited
EP0147939A2
Cited
US4686098A
Cited
EP0161640A2
Cited
EP0188309A2
Cited
US4902295A
Cited
WO1987004367A1
Cited
GB2189809A
Cited
GB2192171A
Cited
US4892538A
Cited
US5158881A
Cited
US5284761A
Cited
US4902450A
Cited
EP0363125A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-02-13 | 1998-08-15 | 1999-02-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-02-13 | 2002-08-15 | 2003-02-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-02-13 | 2006-08-15 | 2007-02-14 | $7700.00 | Window Closed / Lapsed |